Abstract
The global COVID-19 pandemic has had a serious impact on cancer treatment. Oncologists must now incorporate the risks of coronavirus infection into their decision making. Precision medicine tools identifying the most appropriate treatment strategies for individual patients has never been more important Two recent articles published in the journal Colorectal Cancer address this issue from the US and Latin America perspective and provide considerations for optimizing the treatment of patients with colorectal cancer whilst minimizing the risk of coronavirus infection. This video brings together the authors of both publications to discuss their articles and provide their own personal experiences using risk-assessment tools such as Immunoscore in triaging colorectal cancer patients. This international discussion provides oncologists and other healthcare professionals with valuable insights into the multidisciplinary approaches to colorectal cancer management that are needed on the COVID-19 era.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
